Literature DB >> 23986804

Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes.

Dieter A Kubli1, Melissa N Quinsay, Asa B Gustafsson.   

Abstract

Autophagy plays a critical role in cellular quality control and is involved in removing damaged or excess organelles. Dysfunctional mitochondria are quickly cleared from the cell by autophagosomes before they can cause damage to the cell. Parkin is an E3 ubiquitin ligase that selectively ubiquitinates proteins on dysfunctional mitochondria, thereby marking those mitochondria for degradation by autophagosomes. In our recent study, we investigated the functional role of Parkin in the myocardium and discovered that Parkin is dispensable in the adult heart under normal conditions. Instead, our findings suggest that Parkin plays an important role in clearing damaged mitochondria in myocytes during stress. Here, we report that Parkin deficiency results in the accumulation of abnormal mitochondria in myocytes with age.

Entities:  

Keywords:  aging; autophagy; heart failure; mitochondria; parkin

Year:  2013        PMID: 23986804      PMCID: PMC3737749          DOI: 10.4161/cib.24511

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


Autophagy plays an important role in cellular quality control as it degrades protein aggregates and dysfunctional organelles that can be harmful to the cell. In the heart, mitochondria are responsible for providing myocytes with energy in the form of ATP to sustain contraction. However, in response to stress, mitochondria can change to organelles that promote cell death, as they become producers of reactive oxygen species and release pro-apoptotic proteins such as cytochrome c. To prevent unnecessary death, a dysfunctional mitochondrion can be selectively removed from the cell through mitochondrial autophagy, or mitophagy. The specific targeting of mitochondria for autophagic degradation has recently been shown to involve a family of proteins found to be mutated in familial Parkinson disease (PD)., One such protein, Parkin, is an E3 ubiquitin ligase that rapidly translocates to dysfunctional mitochondria where it promotes ubiquitination of mitochondrial proteins, which serves as a signal for mitophagy., We recently demonstrated that Parkin plays an important role in adapting to stress in the myocardium. We discovered that 12-week old Parkin-deficient mice (Parkin−/−) have normal cardiac function under baseline conditions. At this age, Parkin−/− mice also have normal cardiac mitochondrial function, although mitochondria appear smaller and clustered. However, in response to myocardial infarction (MI), these mice suffer exaggerated cardiac damage and increased mortality compared with wildtype (WT) mice. The increased severity of tissue damage in Parkin−/− mice is associated with rapid accumulation of swollen, dysfunctional mitochondria in the infarct border zone that is consistent with a defect in mitochondrial clearance. Taken together, these results suggest that a Parkin-independent, alternative pathway of mitophagy is present and may account for the normal appearance and function of mitochondria in 12-week-old Parkin−/− mice at baseline. This pathway may become overwhelmed following MI, allowing dysfunctional mitochondria to accumulate. Continuous turnover of mitochondria via autophagy is important in maintaining a healthy population of mitochondria in cells. Impaired autophagy results in accumulation of dysfunctional mitochondria and is linked to aging and development of heart failure.- In our study, we found that mitochondria in hearts of 3-month-old Parkin−/− mice were disorganized and often found in large clusters with many small, round mitochondria. Interestingly, the change in morphology did not affect mitochondrial function. Here, we used electron microscopy to examine mitochondria in hearts of 6-month-old WT and Parkin−/− mice. Similarly to the 3-month-old mice, mitochondria from aged Parkin−/− mice were disarrayed, smaller and clustered, but still maintained cristae density and appeared generally normal (Fig. 1). However, at this age, we also observed the appearance of abnormal mitochondria containing electron-dense macromolecules in the matrix in Parkin−/− hearts. These findings suggest that alternative pathways of mitochondrial clearance can compensate for loss of Parkin under normal conditions. Our findings also suggest that clearance occurs at a slower rate and therefore abnormal mitochondria start to accumulate with age. The reduced rate of clearance might also account for the accumulation of dysfunctional mitochondria in the heart after MI. It is not surprising that there are redundant pathways involved in mitochondrial clearance; this ensures that there is no disruption in the removal of dysfunctional and potentially harmful mitochondria in cells.

Figure 1. Transmission electron micrographs of heart sections from 6-month-old mice. Images are representative of > 15 photos taken from 2 animals per group. Arrowheads signify abnormally dense mitochondria.

Figure 1. Transmission electron micrographs of heart sections from 6-month-old mice. Images are representative of > 15 photos taken from 2 animals per group. Arrowheads signify abnormally dense mitochondria. The propensity for Parkin−/− mice to suffer from more severe infarcts during MI and the accumulation of damaged mitochondria over time may have serious implications for human patients with mutations in the PARK2 gene encoding Parkin. Aside from the obvious risk of developing early onset PD, these patients may be at a higher risk for fatal myocardial infarction, a risk which most likely increases with age as abnormal mitochondria accumulate in the myocytes. An early epidemiological study found a correlation between PD and increased risk of ischemic heart disease (IHD). PD patients have a greater than 2 fold risk of death from IHD and have significantly higher mortality than control patients. Additionally, mutations in the PARK2 gene may be present in as high as 18% of PD cases with onset before age 40, and may account for 50% of early-onset autosomal recessive PD cases. Moreover, although more than 100 disease-causing mutations in the PARK2 gene have been identified to date, the structure and function of cardiac mitochondria in PD patients have not been evaluated. Dysfunctional mitochondria have been identified in the brains and skeletal muscle of PD patients. Of greater relevance, impaired mitochondrial function has been found in leukocytes of patients with mutations in PARK2. Clearly, a more in-depth investigation is necessary to ascertain whether mutations in the PARK2 gene are associated with elevated mortality due to heart-related issues. This information could be critical in improving longevity and quality of life for Parkinson disease patients.

Material and Methods

Transmission electron microscopy

TEM was performed as previously described. Briefly, hearts were harvested from six-month-old mice, fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, post-fixed in 1% osmium tetroxide, and then treated with 0.5% tannic acid, 1% sodium sulfate, cleared in 2-hydroxypropyl methacrylate and embedded in LX112 (Ladd Research). Sections were mounted on copper slot grids coated with parlodion and stained with uranyl acetate and lead citrate for examination on a Philips CM100 electron microscope (FEI).
  17 in total

1.  Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations.

Authors:  Meltem Müftüoglu; Bülent Elibol; Ozlem Dalmizrak; Ayse Ercan; Gülnihal Kulaksiz; Hamdi Ogüs; Turgay Dalkara; Nazmi Ozer
Journal:  Mov Disord       Date:  2004-05       Impact factor: 10.338

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

3.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

Review 4.  Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities.

Authors:  Debapriya Dutta; Riccardo Calvani; Roberto Bernabei; Christiaan Leeuwenburgh; Emanuele Marzetti
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

5.  PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.

Authors:  Cristofol Vives-Bauza; Chun Zhou; Yong Huang; Mei Cui; Rosa L A de Vries; Jiho Kim; Jessica May; Maja Aleksandra Tocilescu; Wencheng Liu; Han Seok Ko; Jordi Magrané; Darren J Moore; Valina L Dawson; Regis Grailhe; Ted M Dawson; Chenjian Li; Kim Tieu; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

Review 6.  Mitochondria and mitophagy: the yin and yang of cell death control.

Authors:  Dieter A Kubli; Åsa B Gustafsson
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

7.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.

Authors:  Atsuko Nakai; Osamu Yamaguchi; Toshihiro Takeda; Yoshiharu Higuchi; Shungo Hikoso; Masayuki Taniike; Shigemiki Omiya; Isamu Mizote; Yasushi Matsumura; Michio Asahi; Kazuhiko Nishida; Masatsugu Hori; Noboru Mizushima; Kinya Otsu
Journal:  Nat Med       Date:  2007-04-22       Impact factor: 53.440

8.  Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease.

Authors:  L A Bindoff; M A Birch-Machin; N E Cartlidge; W D Parker; D M Turnbull
Journal:  J Neurol Sci       Date:  1991-08       Impact factor: 3.181

9.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

10.  Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?

Authors:  Y Ben-Shlomo; M G Marmot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

View more
  54 in total

1.  Mitophagy and Mitochondrial Quality Control Mechanisms in the Heart.

Authors:  Roberta A Gottlieb; Amandine Thomas
Journal:  Curr Pathobiol Rep       Date:  2017-05-02

Review 2.  How mitochondrial dynamism orchestrates mitophagy.

Authors:  Orian S Shirihai; Moshi Song; Gerald W Dorn
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

Review 3.  Mending a broken heart: the role of mitophagy in cardioprotection.

Authors:  Alexandra G Moyzis; Junichi Sadoshima; Åsa B Gustafsson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-26       Impact factor: 4.733

4.  Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.

Authors:  Kai-Chun Yang; Xiucui Ma; Haiyan Liu; John Murphy; Philip M Barger; Douglas L Mann; Abhinav Diwan
Journal:  Circ Heart Fail       Date:  2014-10-22       Impact factor: 8.790

5.  Parkin clearance of dysfunctional mitochondria regulates ROS levels and increases survival of human chondrocytes.

Authors:  M Y Ansari; N M Khan; I Ahmad; T M Haqqi
Journal:  Osteoarthritis Cartilage       Date:  2017-08-08       Impact factor: 6.576

Review 6.  New methods for monitoring mitochondrial biogenesis and mitophagy in vitro and in vivo.

Authors:  Jessica A Williams; Katrina Zhao; Shengkan Jin; Wen-Xing Ding
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

7.  Effects of Running Wheel Activity and Dietary HMB and β-alanine Co-Supplementation on Muscle Quality in Aged Male Rats.

Authors:  D W Russ; C Acksel; K W McCorkle; N K Edens; S M Garvey
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 8.  Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease.

Authors:  Amabel M Orogo; Åsa B Gustafsson
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

Review 9.  Parkin-dependent mitophagy in the heart.

Authors:  Gerald W Dorn
Journal:  J Mol Cell Cardiol       Date:  2015-11-22       Impact factor: 5.000

Review 10.  Mitochondrial quality control in the diabetic heart.

Authors:  Qiangrong Liang; Satoru Kobayashi
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.